These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18085432)

  • 61. Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection.
    Fabbiani M; Di Giambenedetto S; Cingolani A; Fanti I; Colafigli M; Tamburrini E; Cauda R; Navarra P; De Luca A; Murri R
    Infect Dis (Lond); 2016; 48(1):48-55. PubMed ID: 26329383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improving clinic attendance and adherence to antiretroviral therapy through a treatment supporter intervention in Uganda: a randomized controlled trial.
    Kunutsor S; Walley J; Katabira E; Muchuro S; Balidawa H; Namagala E; Ikoona E
    AIDS Behav; 2011 Nov; 15(8):1795-802. PubMed ID: 21424272
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
    Stone VE; Jordan J; Tolson J; Miller R; Pilon T
    J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
    Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Modified directly observed therapy to facilitate highly active antiretroviral therapy adherence in Beira, Mozambique. Development and implementation.
    Pearson CR; Micek M; Simoni JM; Matediana E; Martin DP; Gloyd S
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(Suppl 1):S134-41. PubMed ID: 17133197
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancing adherence to antiretrovirals: strategies and regimens.
    Stone VE
    MedGenMed; 2002 Jul; 4(3):22. PubMed ID: 12466765
    [No Abstract]   [Full Text] [Related]  

  • 67. Directly observed therapy for the management of HIV-infected patients in a methadone program.
    Conway B; Prasad J; Reynolds R; Farley J; Jones M; Jutha S; Smith N; Mead A; DeVlaming S
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S402-8. PubMed ID: 15156430
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project.
    Parsons JT; Rosof E; Punzalan JC; Di Maria L
    AIDS Patient Care STDS; 2005 Jan; 19(1):31-9. PubMed ID: 15665633
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Velloza J; Kemp CG; Aunon FM; Ramaiya MK; Creegan E; Simoni JM
    AIDS Behav; 2020 Jun; 24(6):1727-1742. PubMed ID: 31673913
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of illicit drug use and substance abuse treatment on adherence to HAART.
    Hicks PL; Mulvey KP; Chander G; Fleishman JA; Josephs JS; Korthuis PT; Hellinger J; Gaist P; Gebo KA;
    AIDS Care; 2007 Oct; 19(9):1134-40. PubMed ID: 18058397
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.
    Spire B; Carrieri P; Sopha P; Protopopescu C; Prak N; Quillet C; Ngeth C; Ferradini L; Delfraissy JF; Laureillard D
    Antivir Ther; 2008; 13(5):697-703. PubMed ID: 18771053
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.
    Tran BX; Ohinmaa A; Duong AT; Nguyen LT; Vu PX; Mills S; Houston S; Jacobs P
    Drug Alcohol Depend; 2012 Oct; 125(3):260-6. PubMed ID: 22436971
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).
    Cingolani A; Antinori A; Rizzo MG; Murri R; Ammassari A; Baldini F; Di Giambenedetto S; Cauda R; De Luca A
    AIDS; 2002 Feb; 16(3):369-79. PubMed ID: 11834948
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.
    Gross R; Yip B; Lo Re V; Wood E; Alexander CS; Harrigan PR; Bangsberg DR; Montaner JS; Hogg RS
    J Infect Dis; 2006 Oct; 194(8):1108-14. PubMed ID: 16991085
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
    Merenstein DJ; Schneider MF; Cox C; Schwartz R; Weber K; Robison E; Gandhi M; Richardson J; Plankey MW
    Pediatrics; 2008 Apr; 121(4):e787-93. PubMed ID: 18381507
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.
    Andrade AS; McGruder HF; Wu AW; Celano SA; Skolasky RL; Selnes OA; Huang IC; McArthur JC
    Clin Infect Dis; 2005 Sep; 41(6):875-82. PubMed ID: 16107989
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: the healthy living project randomized controlled study.
    Johnson MO; Charlebois E; Morin SF; Remien RH; Chesney MA;
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):574-80. PubMed ID: 18193499
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Recommendations from GESIDA/SEFH/PNS to improve adherence to antiviral treatment (2004)].
    Knobel H; Escobar I; Polo R; Ortega L; Martín-Conde MT; Casado JL; Codina C; Fernández J; Galindo MJ; Ibarra O; Llinas M; Miralles C; Riera M; Fumaz CR; Segador A; Segura F; Chamorro L
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):221-31. PubMed ID: 15826548
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
    Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
    AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.